Gain a broader understanding of FDA enforcement trends across pharmaceutical and medical device operations with ComplyFDA's Quarterly Combination Products Insider Intelligence Report. Explore FDA warning letters, cGMP citations, QMSR and ISO 13485:2016 quality system deficiencies, design controls, CAPA, process validation, manufacturing compliance, and regulatory concerns involving 21 CFR Parts 211, 820, and 803. Designed for Regulatory Affairs, Quality Assurance, Compliance, R&D, and Manufacturing professionals managing combination product regulatory risks and seeking actionable intelligence to support FDA inspection readiness, quality system oversight, and compliance improvements.